There was drama earlier this year between Apple and health tech firm Masimo.
The Apple Watch Series 9 and Apple Watch Ultra 2 faced a potential import ban into the U.S. over a pulse oximeter patent dispute.
Despite an International Trade Commission (ITC) ruling against Apple for patent infringement, the smartwatches continue to be sold without the pulse oximeter feature.
This development follows a series of legal and regulatory hurdles, culminating in Apple’s decision to disable the feature to comply with the ITC’s orders.
Interestingly, reports suggest a pathway for the reactivation of the pulse oximeter—a tool for measuring blood oxygen levels, feature in the future.
The Customs and Border Patrol’s (CBP) original order permits Apple to import the watches with the feature disabled, not removed.
This means that, pending patent expiration in August 2028 or a successful appeal by Apple, users could potentially regain access to the pulse oximeter.
Apple’s compliance with CBP’s requirements involved providing the code used to disable the feature, ensuring it wasn’t trivially reactivated, yet leaving a door open for its return under specific conditions.
Even so, after the ITC’s decision that Apple had infringed on Masimo’s patents, Apple temporarily removed the Series 9 and Ultra 2 models from its U.S. stores.
Despite efforts to appeal the ruling and a brief temporary stay, the tech giant has had to reconfigure its latest smartwatches to exclude the pulse oximete.
The absence of a veto from President Biden has left Apple with limited options, leading to the current sale of these devices without the disputed feature.
Due to a patent dispute with Masimo, Apple was required to disable the pulse oximeter feature in these models to comply with an ITC ruling.
Yes, the feature has the potential to be reactivated in the future, depending on the outcome of patent expiration or Apple’s ongoing legal appeal.
Apple temporarily removed the Series 9 and Ultra 2 models from its U.S. stores following an ITC ruling that found Apple infringed on Masimo’s patents.
Apple provided the code used to disable the pulse oximeter feature, ensuring compliance with the CBP’s requirements while leaving the possibility of reactivation open under certain conditions.
The reinstatement could occur if Apple’s patents infringed on expire in August 2028 or if Apple wins the appeal it has in progress, allowing users to access the feature again.
Also Read: Apple Watch Series 9 and Ultra 2 Revealed: Next-Gen Tech Meets Sustainability
Also Read: Apple Watch Series 9 and Ultra 2 As Exercise Rewards? Check Out How
Highlights Honor introduced the Play 80 Pro and X80i in China. Play 80 Pro offers…
Highlights Realme has announced price increases across its C‑series, P‑series and number series smartphones. Most…
Highlights Motorola has revised the Moto G06 pricing with all variants now at ₹9,999. Key…
Highlights Redmi has raised prices for Redmi 15C 5G, Redmi 15 5G and Redmi Note…
Highlights Vivo V70 FE launched in India with a 200MP main sensor, Aura Light support…
Highlights Realme 16 5G launched in India at the starting price of ₹28,999 for the…
This website uses cookies.